AMGN vs L · P/E 24, rev $10.05B vs P/E 14, rev $18.45B
Amgen Inc (AMGN) versus Loews Corp (L) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. L currently screens at market cap $22.36B and trailing P/E 13.8.
Not investment advice. Open the AMGN and L stock pages for the full models.
Not investment advice.